QUARTERLY RESULTS Shilpa Medicare Q4 Results: Net profit jumps over 7x to Rs 108 crore, revenue up 32% 3:08 PM IST
CORPORATES Shilpa Medicare signs strategic licensing agreement with SteinCares to commercialize biosimilar in Latin America Feb 24, 2026
QUARTERLY RESULTS Shilpa Medicare Q3 Results: Revenue jumps 28.3% YoY to Rs 409.73 crore, net profit up 40.3% Feb 6, 2026
Shilpa Medicare’s Bengaluru facility secures GMP approval from EMA for Oral Mouth Dissolving Films and Transdermal Systems May 6, 2025
Shilpa Medicare subsidiary signs exclusive deal with Switzerland-based mAbTree Biologics AG Mar 17, 2025
Shilpa Medicare subsidiary receives one observation from USFDA for Unit-1 facility in Raichur Mar 7, 2025
Shilpa Medicare secures Portugal marketing authorization for Tadalafil Orodispersible Films Jan 10, 2025